Skip to content

China Acquired Hemophilia Registry

China Acquired Hemophilia Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-17013381
Enrollment
Unknown
Registered
2017-11-14
Start date
2011-04-20
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Hemophilia

Interventions

Case series:Nil

Sponsors

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed with acquired hemophilia A; 2. FVIII:C <50IU/dL; 3. FVIII inhibitor positive; 4. Informed consent was signed; 5. No restriction of age.;Inclusion criteria: 1. Diagnosed with acquired hemophilia A; 2. FVIII:C <50IU/dL; 3. FVIII inhibitor positive; 4. Informed consent was signed; 5. No restriction of age.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with hereditary hemophilia A; 2. Non-FVIII inhibit or VWF or other coagulation factors.;Exclusion criteria: 1. Diagnosed with hereditary hemophilia A; 2. Non-FVIII inhibit or VWF or other coagulation factors.

Design outcomes

Primary

MeasureTime frame
FVIII: C(%);inhibitor titer;;FVIII: C(%);inhibitor titer;

Contacts

Public ContactYang renchi;Yang renchi ;

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

rcyang65@163.com;rcyang65@163.com+86 02223909063;+86 02223909063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026